2022
DOI: 10.1016/j.jconrel.2022.10.024
|View full text |Cite
|
Sign up to set email alerts
|

In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 78 publications
0
1
0
Order By: Relevance
“…55,56 In 2019, Simon et al 57 performed isoniazid drug delivery using MIL-100(Fe) MOFs for the first time. Similarly, Gaweł et al 58 and Acharya et al 59 performed the isoniazid drug delivery using Fe-MIL-101-NH 2 and BIO-MOF-100 but did not determine the antibacterial activity of the released isoniazid. A study by demonstrates the application of mixed ligand Cu-MOFs (MOFs-2) as a drug delivery vehicle for the release of an anthracycline antibiotic, Doxorubicin hydrochloride (DOX).…”
Section: Introductionmentioning
confidence: 99%
“…55,56 In 2019, Simon et al 57 performed isoniazid drug delivery using MIL-100(Fe) MOFs for the first time. Similarly, Gaweł et al 58 and Acharya et al 59 performed the isoniazid drug delivery using Fe-MIL-101-NH 2 and BIO-MOF-100 but did not determine the antibacterial activity of the released isoniazid. A study by demonstrates the application of mixed ligand Cu-MOFs (MOFs-2) as a drug delivery vehicle for the release of an anthracycline antibiotic, Doxorubicin hydrochloride (DOX).…”
Section: Introductionmentioning
confidence: 99%